Capital Fund Management S.A. Sells 84,803 Shares of CME Group Inc. (NASDAQ:CME)

Capital Fund Management S.A. decreased its stake in shares of CME Group Inc. (NASDAQ:CMEGet Rating) by 57.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 63,430 shares of the financial services provider’s stock after selling 84,803 shares during the quarter. Capital Fund Management S.A.’s holdings in CME Group were worth $14,491,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Meridian Wealth Advisors LLC raised its holdings in shares of CME Group by 1.3% during the third quarter. Meridian Wealth Advisors LLC now owns 3,483 shares of the financial services provider’s stock valued at $674,000 after acquiring an additional 46 shares during the last quarter. Exchange Capital Management Inc. raised its stake in CME Group by 2.1% during the fourth quarter. Exchange Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock worth $557,000 after acquiring an additional 49 shares during the period. Veriti Management LLC lifted its position in shares of CME Group by 1.0% in the 4th quarter. Veriti Management LLC now owns 5,327 shares of the financial services provider’s stock valued at $1,217,000 after acquiring an additional 52 shares in the last quarter. Kestra Private Wealth Services LLC grew its stake in CME Group by 2.9% in the 4th quarter. Kestra Private Wealth Services LLC now owns 1,873 shares of the financial services provider’s stock valued at $428,000 after buying an additional 53 shares during the last quarter. Finally, Alera Investment Advisors LLC lifted its holdings in CME Group by 2.1% during the 4th quarter. Alera Investment Advisors LLC now owns 2,976 shares of the financial services provider’s stock valued at $680,000 after purchasing an additional 61 shares during the last quarter. 86.71% of the stock is owned by institutional investors.

A number of equities research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $235.00 to $260.00 and gave the company a “hold” rating in a research note on Thursday, February 10th. Morgan Stanley upped their price target on CME Group from $255.00 to $271.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 13th. StockNews.com initiated coverage on CME Group in a report on Thursday, March 31st. They set a “hold” rating on the stock. JPMorgan Chase & Co. reduced their price objective on CME Group from $202.00 to $201.00 and set a “neutral” rating for the company in a research note on Thursday, February 10th. Finally, Compass Point upped their price objective on CME Group from $235.00 to $250.00 and gave the stock a “neutral” rating in a research report on Thursday, February 10th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $254.75.

In other CME Group news, insider Sean Tully sold 4,000 shares of the company’s stock in a transaction dated Monday, March 14th. The shares were sold at an average price of $229.80, for a total value of $919,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Daniel R. Glickman sold 750 shares of the firm’s stock in a transaction on Tuesday, March 1st. The stock was sold at an average price of $234.30, for a total value of $175,725.00. The disclosure for this sale can be found here. Insiders sold a total of 16,150 shares of company stock valued at $3,786,944 in the last quarter. 0.30% of the stock is currently owned by company insiders.

Shares of NASDAQ CME traded down $2.61 during mid-day trading on Thursday, hitting $196.01. The company had a trading volume of 2,572,514 shares, compared to its average volume of 1,720,757. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.01. The stock has a market cap of $70.45 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 4.34 and a beta of 0.47. The firm’s 50 day simple moving average is $232.31 and its two-hundred day simple moving average is $229.79. CME Group Inc. has a 12 month low of $185.79 and a 12 month high of $256.94.

CME Group (NASDAQ:CMEGet Rating) last released its earnings results on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.00 by $0.11. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The company’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.79 EPS. Equities analysts forecast that CME Group Inc. will post 7.9 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, June 27th. Stockholders of record on Friday, June 10th will be issued a dividend of $1.00 per share. The ex-dividend date is Thursday, June 9th. This represents a $4.00 annualized dividend and a dividend yield of 2.04%. CME Group’s payout ratio is 52.22%.

CME Group Profile (Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEGet Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.